<DOC>
	<DOCNO>NCT01952743</DOCNO>
	<brief_summary>We propose pilot study assess safety benefit renal artery ablation time plan atrial fibrillation ablation .</brief_summary>
	<brief_title>Renal Denervation Therapy Hypertensive Patients Undergoing A-Fib Ablation</brief_title>
	<detailed_description>Symptomatic atrial fibrillation ( AF ) refractory anti-arrhythmic drug commonly treat ablation therapy . Pulmonary vein isolation along additional substrate medication commonly perform ablation procedure associate 60-80 % success rate maintenance sinus rhythm . After AF ablation hypertension ( HTN ) strong predictor recurrence atrial fibrillation . Drug resistant hypertension effectively treat catheter base renal denervation therapy . Our primary hypothesis concomitant renal denervation therapy along AF ablation associate improvement success rate AF ablation along adequate control blood pressure . The specific objective study prospectively compare success rate , time AF recurrence , AF burden blood pressure control patient randomize concomitant renal denervation arm compare patient AF ablation alone .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Paroxysmal Persistent Atrial Fibrillation refractory eligible AF ablation per HRS/ECAS/EHRA consensus statement . [ 23 ] Paroxysmal AF define two episode AF last less 7 day duration last 6 month enrollment . Persistent AF define AF last 7 day require cardioversion termination . 2 . Hypertension ( &gt; 140/80 mm Hg ) treatment least 1 hypertensive medication . 3 . GFR &gt; 60ml/dl use Cockcroft Gault equation 1 . Secondary cause hypertension 2 . Severe renal artery stenosis dual renal artery 3 . Congestive heart failure NYHA class III IV status 4 . EF &lt; 35 % 5 . LA Diameter &gt; 6 cm 6 . Previous AF ablation 7 . Previous renal artery stent angioplasty 8 . Severe contrast allergy 9 . Inability give inform consent 10 . Solitary kidney</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Renal Denervation</keyword>
</DOC>